Our inspiration, mentor, teacher, counselor, colleague, friend, and guiding light. May we honor his legacy in our continued work to improve outcomes in lung cancer through our study of lung cancer development, biomarkers, and early detection. Every step forward will be taken down a path you have paved. May we always be inspired by patients, driven by science, and empowered by each other.
Biomarker-informed management of indeterminate pulmonary nodules. Biomarkers can reduce the rate of overtreatment in benign nodules and reduce the time to treatment for cancer.
Natural history of lung cancer
Molecular determinants of lung cancer risk
Amino Acid Transporters regulating Gln metabolism
Molecular imaging of lung cancer with a glutamate analog
Lung Collaborative Group
Quantitative imaging structural analysis
High sensitivity CYFRA 21-1 by Interferometry
Massion et al. AJRCCM 2020
LCP CNN deep learning model reclassifies indeterminate pulmonary nodules
Massion lab 2020
Molecular and Cellular Characterization of Early lung ADC
What distinguishes Indolent from Aggressive lung ADC?
MASLAB September 2022

Inspired by Patients, Driven by Science

Inspired by Patients, Driven by Science